China · Research startup
China · Abogen Biosciences
Abogen Biosciences is a clinical-stage biotechnology company focused on RNA-based medicines, particularly in mRNA science and technology.
Funding reportedLast round: Venture (Round not Specified)
About Abogen Biosciences
Abogen Biosciences is a clinical-stage biotechnology company focused on RNA-based medicines, particularly in mRNA science and technology.
The company aims to develop transformative therapies and vaccines to address untreatable diseases. It operates under the name Suzhou Abogen Biosciences Co., Ltd., with offices located in Suzhou, Shanghai, and Beijing. Abogen has integrated in-house technologies that support the full development cycle of mRNA medicines, including target selection, mRNA optimization, GMP production, and clinical delivery. Its pipeline includes candidates targeting varicella zoster virus (VZV), respiratory syncytial virus (RSV), and tuberculosis (TB).
What company datasets say Abogen Biosciences raised
Funding, as reported
Founders and team
From Abogen Biosciences's own website: 1 founder, 7 on the team.
- Xiaotao WangVice President of Platform Biology
- Xinpeng MaSenior Vice President of Chemistry
- Zhiyi ZhangVice President of Formulation R&D
- Iain McFadyenChief AI Officer
- Peng GaoChief Technology Officer
- Wenjie SongChief Medical Officer
- Ziyi SongChief Financial Officer
On 3 portfolio pages
Investors who name them
Each firm lists Abogen Biosciences on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
patented lipid formulationsb2bprotein engineeringhospital & health carehealthcare equipment & supplieshealth careoncologyself-amplifying rna (sarna)proprietary technologyscalable manufacturingai-driven drug designcancer immunotherapymedicalai-enhanced rna designvaccine developmentbiotechnology research
Built with from their website
Wagtail CMSaThemes MoesiaeDirectoryLOURSAPSecured MVC Forum on Windows 2012 R2HPLCSlim SEOSentenceTransformers
+8 more
Microsoft Advanced Group Policy ManagementAutoclaveANSGraphyFortinetModeXtraHomestead
- Sector
- Research
- Industry code
- NAICS 541714, 325414, SIC 2834, 2836
- Revenue
- 4.5M a year, as listed
Research in China
Startups like it
CMAB BiopharmaSuzhou · founded 2017Raised
HaploX BiotechnologyShenzhen Shi · founded 2014Raised
TriArm Therapeuticsfounded 2018Raised
Cure GeneticsSuzhou · founded 2016Raised
BGI GroupShenzhen Shi · founded 1999
Baiming Xinkang Biotechnology (Hangzhou) Co., Ltd. Worgpharma)Hang Zhou Shi · founded 2018
Chengdu Qitan Technology Co., Ltd.Beijing · founded 2016- Hangzhou DAC Biotech Co., Ltd.Hangzhou · founded 2012
Is this your company?
Add your raise, your deck and your story, and put Abogen Biosciences in front of investors. Or tell us what we have wrong.